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(57)	 ABSTRACT
Methods of utilizing magnetic particles or beads (MBs) in
droplet-based (or digital) microlluidics are disclosed. The
methods may be used in enrichment or separation processes.
A first method employs the droplet meniscus to assist in the
magnetic collection and positioning of MBs during droplet
microlluidic operations. The sweeping movement of the
meniscus lifts the MBs off the solid surface and frees them
from various surface forces acting on the MBs. A second
method uses chemical additives to reduce the adhesion of
MBs to surfaces. Both methods allow the MBs on a solid
surface to be effectively moved by magnetic force. Droplets
may be driven by various methods or techniques including,
for example, electrowetting, electrostatic, electromechanical,
electrophoretic, dielectrophoretic, electroosmotic, ther-
mocapillary, surface acoustic, and pressure.
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METHOD FOR USING MAGNETIC
PARTICLES IN DROPLET MICROFLUIDICS
REFERENCE TO RELATED APPLICATIONS
5
This Application claims priority to U.S. Provisional Patent
Application No. 61/053,558 filed on May 15, 2008. U.S.
Provisional Patent Application No. 61/053,558 is incorpo-
rated by reference as if set forth fully herein.
10
STATEMENT REGARDING FEDERALLY
SPONSORED RESEARCH AND DEVELOPMENT
This invention was made with Government support of
Grant No. NCC21364 awarded by the National Aerospace 15
and Space Administration (NASA) and Grant No. AI065359
awarded by the National Institutes of Health (NIH). The
Government has certain rights in this invention.
FIELD OF THE INVENTION	 20
The field of the invention generally relates to droplet-based
(also called digital) microfluidic devices and methods. More
specifically, the field of the invention relates to the use of
magnetic particles or beads in conjunction with droplet 25
microfluidic operations. The method may be used to assist in
the collection and positioning of magnetic particles or beads,
including superparamagnetic and immunomagnetic ones.
BACKGROUND OF THE INVENTION	 30
Target concentration and separation using magnetic beads
(hereinafter MBs), for their unique advantages, have been
gaining popularity in biochemical practice including microf-
luidics. These techniques may be used for purification of 35
bodily fluids. See e.g., 0.Olsvik, T. Popovic, E. Skjerve, K. S.
Cudjoe, E. Homes, J. Ugelstad, and M. Uhlen, "Magnetic
Separation Techniques in Diagnostic Microbiology", Clini-
cal Microbiology Reviews, Vol. 7, pp. 43-54,1994. Still others
have employed magnetic to isolate specific cells from blood 40
samples. See e.g., V. I. Furdui and D. J. Harrison, "Immuno-
magnetic T Cell Capture From Blood For PCR Analysis
Using Microfluidic Systems," Lab on a Chip, Vol. 4, pp.
614-618,2004. In a typical procedure, the MBs are held back
(i.e., trapped) on a surface position by magnetic force, while 45
a fluid passes by or over the MBs. When the fluid contains
targets, these targets build on the MB surface and thus
become concentrated, as the MBs have a special affinity to the
targets. When the fluid is exchanged with a wash fluid, all the
particles and species except the targets on the MBs are 50
washed away and separated (i.e., the targets on the MBs are
purified). In the case of a typical prior art immunoassay, the
target is a protein, and the MBs are conjugated with antibody
(Ab). This prior art technique is described in FIGS. 1A-G. As
seen in FIG. 1A, MBs conjugated withAb are introduced as a 55
suspension in a liquid. As seen in FIG. 113, the antibody
(Ab)-conjugated MBs are then trapped at a location on the
surface of the device using an external magnet.
Next, as seen in FIG. 1C, a sample of proteins, that includes
both the target protein and non-target proteins, are permitted 60
to flow into the device and past the antibody (Ab)-conjugated
MBs trapped at the surface of the device. Referring now to
FIG. 1D, target proteins bind to the Ab that is conjugated to
the MBs. Unbound non-target proteins are washed away with
a wash solution.	 65
Optionally, as seen in FIG. 1E, labeled antibody (Ab) is
then permitted to flow into the device. The labeled Ab will
2
then bind to those Ab-conjugated MBs that are already bound
with target protein. In this regard, the labeled Ab will sand-
wich the target protein. The labeled Ab may include a fluo-
rescent label that fluoresces in response to incident radiation.
Unbound labeled Ab is then washed away as illustrated in
FIG. 1F. Detection or analysis or any other processes may
optionally be performed on the sample. The magnet may then
be removed as illustrated in FIG. 1G, and the MBs and targets
(as well as, optionally, their conjugated labels) may then be
washed away from the surface of the device, for further pro-
cesses or operations with this purified sample.
The above prior art process applies to conventional condi-
tions, where liquids move between containers in bulk or flow
continuously within channels. However, when the fluids are
handled in digitized packets (e.g., droplets), as in droplet-
based digital microfluidics, the above-noted process does not
work because of the existence of liquid-gas or liquid-liquid
interfaces. In particular, as the droplet passes across the posi-
tion where the MBs are to be held, the passing meniscus pulls
the MBs away from the surface with a force that is orders-of-
magnitude stronger than the magnetic force. The magnetic
force produced by even with the strongest magnet available is
not strong enough to counter the interfacial force in the scale
of typical MBs. Because of this strong interfacial force (i.e.,
surface tension) of the meniscus of the droplet, the MBs
cannot be magnetically trapped on the surface against a drop-
let sliding across the surface. Instead, the MBs get carried
away with the moving droplet. The interfacial force is also
much stronger than the short range surface forces (e.g., van
der Waals force) which act on MBs in contact with the device
surface. This is true for commercially available "naked" MBs
(e.g. polystyrene beads) as well as antibody-conjugated MBs
often used for cell selection and protein enrichment, among
many other cases. This, the prior art process envisioned in
FIGS. 1A-1G is inapplicable for droplet-based microfluidic
applications.
SUMMARY OF THE INVENTION
In a first aspect of the invention, a method of manipulating
magnetic particles disposed within a droplet that is located on
or in close proximity to a surface is provided. The method
includes sweeping a meniscus of the droplet so as to lift the
magnetic particles off the surface and applying a magnetic
field to the droplet containing the magnetic particles, the
magnetic field concentrating the magnetic particles in a
region of the droplet. The droplet is then cut at a location
outside of the region containing the magnetic particles.
In a second aspect of the invention, a method of manipu-
lating magnetic particles within a droplet located on or in
close proximity to a surface includes adding a surfactant to at
least one of the droplet, magnetic particles, or the surface and
applying a magnetic field to the droplet containing the mag-
netic particles, the magnetic field concentrating the magnetic
particles in a region of the droplet. The droplet is then cut at a
location outside of the region containing the magnetic par-
ticles.
In another aspect of the invention, a method of concentrat-
ing a target using magnetic particles within a droplet includes
merging a droplet containing the target with a droplet con-
taining magnetic particles having a specific affinity to said
target. A magnetic field is then applied to the merged droplet.
The merged droplet is then moved relative to the magnetic
field to concentrate magnetic particles containing bound tar-
get in a region of the merged droplet and the merged droplet
is then cut at a location outside of the region containing the
magnetic particles containing bound target.
US 8,093,064 B2
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While the invention is described herein as having particular 	 ated, merged, moved, cut, etc. in a reprogrammable fashion
applicability for increasing the concentration of a target spe- 	 using the appropriate actuation sequence. EWOD-based
cies, the invention may also be used to reduce the concentra- 	 devices are able to create, transport, cut and merge droplets in
tion of non-target species.	 a microfluidic environment. For example, the fundamental
5 operations and structures used in EWOD-based devices is
BRIEF DESCRIPTION OF THE DRAWINGS
	 described in Cho et al., "Creating, Transporting, Cutting, and
Merging Liquid Droplets by Electrowetting-Based Actuation
FIGS. 1A-1G illustrate a prior art method of using mag- 	 for Digital Microfluidic Circuits," Journal of Microelectro-
netic beads for concentrating and purifying a target in an	 mechanical Systems, Vol. 12, No. 1, February 2003, pp.
immunoassay using a channel-based, continuous-flow io 70-80, which is incorporated by reference herein. The afore-
microfluidic device. 	 mentioned reference describes common configurations for
FIG. 2A-20 illustrate a method of using meniscus-assisted
	 EWOD although other EWOD configurations may also be
trapping of MBs applied to an immunoassay using a microf- 	 used (e.g., coplanar EWOD, EWOD with ground wire, etc.).
luidic device employing digital microfluidics (e.g., EWOD	 In addition, it should be understood that while the methods
driving of droplets). 	 15 described herein have principally been illustrated having
FIGS. 3A-3D illustrate a cross-sectional view of a microf- 	 EWOD-based driving schemes, other methods of creating,
luidic device employing digital microfluidics (e.g., EWOD	 transporting, mixing, and cutting of droplets may be used. For
driving of droplets) along with a permanent magnet to collect 	 example, besides the electrowetting force, other forces that
MBs.	 can be used in a digital or droplet-based device include elec-
FIGS. 4A-4F illustrate a cross-sectional view of a microf- 20 trostatic forces, electromechanical forces, electrophoretic
luidic device employing digital microfluidics (e.g., EWOD	 forces, dielectrophoretic forces, electroosmotic forces, ther-
driving of droplets) along with a permanent magnet to 	 mocapillary forces, surface acoustic forces, or even pressure
increase the concentration of MBs in a droplet containing a 	 forces. Devices operating on these schemes are contemplated
mixture of MBs (dark circles) and non-MBs (light circles).	 to fall within the scope of the invention.
FIGS. 5A-5E illustrate a method of using meniscus-as-  25	 Referring to FIG. 2A, a sample droplet 20 containing target
sisted trapping of MBs applied to cell enrichment using a 	 proteins (square-shaped elements in FIG. 2A) is manipulated
microfluidic device employing digital microfluidics (e.g., 	 using the EWOD electrodes 10 to merge with a droplet 22
EWOD driving of droplets).	 containing MBs conjugated with antibody or Ab. The droplet
FIGS. 6A-6D illustrate another embodiment of a method
	 22 complex of MBs and Ab (MB-Ab) is merged with the
for enriching the concentration of a target species. In this 30 sample droplet 20 containing target proteins and incubated to
embodiment, the target species is a particular cell type. The	 allow specific binding between the target protein and its
method is employed using a microfluidic device employing 	 respective Ab. While this example illustrates target proteins,
digital microfluidics (e.g., EWOD driving of droplets).
	
	 the target species may include other simple or complex mol-
ecules or even whole cells. With reference to FIG. 213, a
DETAILED DESCRIPTION OF THE 	 35 magnet 12 is brought near the merged droplet 24 containing
ILLUSTRATED EMBODIMENTS
	
	
the target proteins and the MB-Ab. The magnet 12 may be
formed from a permanent magnet such as, for instance, a rare
FIGS. 2A-20 illustrate a method of using meniscus-as-	 earth magnet or it may be formed from an electromagnetic
sisted trapping of MBs applied to an immunoassay using a 	 that may be selectively turned on and off via conventional
microfluidic device employing digital microfluidics. While 40 control circuitry. In the case of a permanent magnet, a suitable
MBs are illustrated in FIGS. 2A-20, the method applies to 	 rare earth magnet may be formed from NdFeB. In FIG. 213,
any magnetic particles including MBs. The term "magnetic 	 the MBs that are suspended in the droplet 24 move toward the
particles" would thus encompass MBs. In the immunoassay	 magnet 12. However, many MBs are brought into contact
application of FIGS. 2A-20, a plurality of electrodes 10	 with the device surface (the surface overlying the electrodes
forming an electrowetting-on-dielectric (EWOD) device are 45 10) by the vertical component of the magnetic force, or grav-
used to manipulate the various droplets described in more	 ity, e.g., during incubation. Once MBs contact this surface,
detail herein. Five (5) separate electrodes 10 are illustrated in	 the magnetic force from the magnet 12 is ineffective in mov-
FIGS. 2A-20 although any number can be used in accordance 	 ing MBs against opposing surface forces. As such, no mean-
with the methods described herein. Generally, an EWOD	 ingful portion of the droplet 24 can be made free of MBs, and
device is formed using a plurality of separate driving elec-  50 the wash-steps by droplet cutting are inefficient.
trodes 10. These driving electrodes may be formed as a plu- 	 The presently described method leverages the powerful
rality of square or other shaped electrodes with adjacent 	 interfacial forces caused by the moving meniscus of the drop-
boundaries (e.g., 1-1.2 mm width) that are driven by an	 let 24 to sweep the MBs off the surface (or MBs in close
applied alternating current (AC) voltage (e.g., 70 V^ c at 1	 proximity to the surface) overlying the electrodes 10 and into
KHz). Electronic control for the activation of the various 55 the droplet, thereby enabling the magnetic force from the
electrodes may be accomplished using various off-chip cir- 	 magnet 12 to move them to one side. As seen in FIGS. 2C and
cuitry. For example, electronic control may be provided using 	 2D, this is achieved by moving the droplet 24 back and forth.
LabVIEW software in conjunction with a digital I/O device. 	 The droplet 24 may be moved back and forth a plurality of
EWOD-based devices may be fabricated using known 	 times or, alternatively, a single back and forth movement may
microfabrication techniques. Generally, it consists of a layer 6o be sufficient to segregate a meaningful amount of MBs to one
of conductive material patterned in the form of electrodes 10 	 side of the droplet 24. In this example, the EWOD electrodes
that is covered by layers of dielectric (e.g. silicon dioxide, 	 10 located on or underneath the surface of the device are used
silicon nitride, parylene) and hydrophobic (e.g. Teflon®, 	 to move the droplet back and forth. It should be appreciated
Cytop(k) materials. By controlling the voltage at each respec-	 that the various droplets that are described herein may be
tive electrode 10, the surface tension (surface energy) can be 65 formed from either a liquid or a gas. The meniscus of the
reversibly manipulated, causing fluid to move in the energeti- 	 various droplets may define a liquid-liquid interface or a
cally favorable direction. For example, droplets can be cre- 	 gas-liquid interface depending on the application.
US 8,093,064 B2
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Now referring to FIG. 2E, once a significant region of the
droplet 24 is cleared of MBs by the magnetic force of magnet
12, the droplet 24 is cut using the electrodes 10 to remove the
unbound (i.e., non-target) proteins. The cut droplet 26 con-
tains the unbound proteins while the now smaller droplet 24
contains the MBs along with the target proteins. The particu-
lar location where the droplet 24 is cut can be controlled by
the underlying electrodes 10. Generally, the droplet 24 is cut
at a location that is outside the region containing the MBs. To
ensure that nearly all the unbound proteins or non-target
proteins are washed away, an optional wash process is used.
For example, FIG. 2F illustrates a droplet 28 containing a
wash or buffer solution that is merged with the portion of
droplet 24 that contains the MBs. The now merged droplet
which is illustrated in FIG. 2G is then moved back and forth
as previously described. This movement is illustrated in
FIGS. 2H and 2I. MBs accumulate on one side of the droplet
near the magnet 12 while unbound proteins remain outside
this region. With reference to FIG. 27, the droplet is then cut
as described above leaving a cut droplet 26 containing the
unbound proteins which can then be removed from the
device.
With reference to FIG. 2K, a droplet 30 containing a
labeled antibodyAb is introduced and merged into the droplet
24 containing the MBs and the target protein. The labeled Ab
may include, for example, fluorescently or enzymatically Ab.
The labeled Ab is incubated with the droplet 24 so as to
"sandwich" the target protein between its two Abs (i.e., theAb
on the MBs and the Ab on the label). As seen in FIG. 2L, the
MBs are again collected and trapped using the meniscus
sweeping technique as described above while the unbound
labeled Abs are removed in a cut droplet 32. As before, one or
more optional wash steps may be performed using a wash or
buffer droplet 28. FIG. 2M illustrates a wash droplet 28 that is
merged with the remaining droplet 24 containing the MBs
and the bound labeled Abs. This merged droplet is then
moved back and forth as described above to sweep the MBs to
one side of the droplet with the aid of the magnet 12. The
droplet 24 is then cut using the EWOD electrodes 10 to
produce a cut droplet 32 having unbound labeled Ab therein.
The remaining droplet 24 seen in FIG. 20 contains concen-
trated target proteins sandwiched between the MB-Ab and
labeled Ab and may be moved to the detection site for further
analysis and/or processing.
FIGS. 3A-3D illustrate a cross-sectional view of a microf-
luidic device employing digital EWOD microfluidics along
with a permanent magnet to collect MBs. This device was
configured as a parallel plate EWOD device. Lithographic
thin-film microfabrication processes were used to fabricate
the parallel-plate EWOD device. In particular, square EWOD
driving electrodes of 1-1.2 mm width were defined from an
indium tin oxide (ITO) (140 mu) layer over a 700 µm-thick
glass substrate (TechGophers Corporation). Cr/Au (-151150
mu) was deposited and patterned to define the contact pads
and electrode labels for easier visualization. Next, a silicon
nitride layer (-1000 mu) was deposited using plasma-en-
hanced chemical vapor deposition (PECVD) and patterned to
define the dielectric layer. A Cytop (Asahi, Inc.) layer (-1000
mu) was spin coated on top and cured at 200° C. to make the
surface layer 14 hydrophobic. A thinner PECVD Si3N4 layer
(-100 mu) was deposited and patterned on it to expose the
ITO for electrical ground connection, followed by Cytop
(-100 mu) deposition. Double-sided tape (-0.1 mm thick;
3M, Inc.) was used as the spacer between the two substrates
sandwiching the droplet(s) 16.
Actuation of the droplets 16 was achieved by applying
voltage typically of —70 VAC at 1 kHz to EWOD electrodes
6
10. Electronic control for the actuation sequence was con-
trolled using LabVIEW software with the help of a digital I/O
device. The magnetic force was provided using a cylindrical
permanent magnet 12 (NdFeB,12.7 mm thick and 12.7 mm in
5 diameter) placed on top of the EWOD device. For MBs,
Dynal-Invitrogen's Dynabeads were used in two sizes: 4.5
µm (M450 epoxy) and 1.0 µm (MyOne Streptavidin TI) in
diameters. Dynabeads have a ferromagnetic core surrounded
by a polystyrene shell, often coated with proteins like strepta-
lo vidin or antibodies, and are, by far, the most commonly used
MBs in biological applications like immunoassays and cell
separation. To eliminate any other additives present in the
MBs' stock solutions, all MBs were washed twice and re-
15 suspended in phosphate-buffered saline (PBS) for EWOD
experiments.
FIG. 3A illustrates the initial leftward movement of the
droplet 16 toward the magnet 12. As best seen in the magni-
fied portion of FIG. 3A, the MBs are swept off the surface 14
20 of the device as the meniscus of the droplet 16 moves in the
left direction as illustrated by the arrows. The droplet 16 is
moved based on actuation of the underlying EWOD elec-
trodes 10 although, as explained herein, other forces may be
employed to move the droplet 16. As the droplet 16 moves to
25 the left, the receding meniscus sweeps the MBs off the surface
14 and into the interior portion of the droplet 16 where the
strong MB-surface interaction is no longer present. FIG. 3B
illustrates additional movement of the droplet 16 in the left-
ward direction whereby all the MBs are collected under the
so magnet 12. FIG. 3C illustrates the droplet 16 moving in the
opposite (i.e., rightward) direction. Again, the droplet 16 is
moved using the underlying EWOD electrodes 10. While the
droplet 16 itself moves in the rightward direction, the MBs
remain concentrated on the left receding meniscus of the
35 droplet 16 because of the magnetic attraction between the
MBs and the magnet 12. With the MBs concentrated on the
left side of the droplet 16, the droplet 16 is then split into two
droplets 16a, 16b. The result of the splitting process is illus-
trated in FIG. 3D. The splitting is accomplished by, for
40 example, actuating EWOD electrodes 10a and l0dinFIG. 3D
while not actuating the intermediate electrodes 10b, 10c. In
this regard, the original droplet 16 is pulled apart or cut into
two smaller droplets 16a, 16b. As seen in FIG. 3D, most of the
MBs are collected in the left droplet 16a while the right
45 "depleted" droplet 16b is free (or substantially free) of MBs.
FIGS. 4A-4F illustrate a process of using the droplet
manipulation method to increase the relative concentration of
MBs in a droplet 16 containing a mixture of MBs (represented
by dark circles) and non-MBs (represented by light circles).
5o The microfluidic device employing digital EWOD microflu-
idics is the same as discussed above with respect to FIGS.
3A-3D. In this experiment, the non-MBs were nonmagnetic
fluorescent beads (FBs), Nile-red fluorescent (535/575 mu)
carboxylate-modified polystyrene microspheres available
55 from Molecular Probes, Inc. (now Invitrogen, Inc.). Exem-
plary sizes of the non-MBs include 2.0 µm diameter (Fluo-
spheres F8825) and 5.3 µm diameter (Interfacial Dynamics
2-FN-5000). As illustrated in FIG. 4A, when a magnet 12 is
introduced over the device, many MBs move toward the mag-
6o net 12. However, the non-MBs and some MBs, particularly
those touching the surface 14, do not migrate off the surface
14 because of the aforementioned forces. As seen in FIG. 413,
the droplet (16) is then moved leftward and the MBs and non
MBs are swept off the surface 14 and re-suspended within the
65 interior of the droplet 16 by the receding meniscus. As seen in
FIG. 4C, the MBs are collected by the magnetic force from
the magnet 12, but the non-MBs are not. The droplet 16 is
US 8,093,064 B2
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moved further to the left until all the MBs and non-MBs on the
surface 14 are swept up by the receding meniscus.
FIG. 4D illustrates the droplet 16 moving back to the right
side of the magnet 12. As seen in FIG. 4D, the MBs are
collected on the left side of the droplet 16 while the non-MBs
distribute uniformly across the droplet 16. The droplet 16 is
then cut or split using EWOD electrodes 10. For example,
EWOD electrodes 10b and 10e may be turned "on" while
electrodes 10c and 10d may be turned in the "off' state. The
droplet 16 is then cut into two smaller droplets 16a, 16b with
most of the MBs remaining in the collected droplet 16a, while
the non-MBs are distributed roughly inproportion to volumes
of the two cut droplets 16a, 16b. Awash droplet 28 containing
buffer can be merged with the droplet 16a and the operations
of FIGS. 4134E may be repeated. In this manner, the non-
MBs can be serially diluted to increase the purity of MBs. For
example, only a few cycles of "sweep-and-cut" may be
needed to substantially deplete the non-MBs. A particular
example of this may be found in Shah et al., "Meniscus-
Assisted High-Efficiency Magnetic Collection and Separa-
tion for EWOD Droplet Microfluidics," Journal of MEMS,
Vol. 18, No. 2, pp. 363-375, April 2009, which is incorporated
by reference as if set forth fully herein.
FIGS. 5A-5E illustrate an embodiment of using meniscus-
assisted trapping of MBs applied to cell enrichment using a
microfluidic device. Inthis embodiment, as illustrated in FIG.
5A, a droplet 40 containing a mixture of cells that are specific
and non-specific cells (e.g., a particular cell type is a target
cell type) is merged with a droplet 42 containing MBs con-
jugated with antibodies that recognize a specific target cell
type. The MBs are allowed to incubate and thus bind to the
specific target cells. As seen in FIG. 513, a magnet 12 is
brought into contact with the device (or in the case of an
electromagnetic the electromagnet is energized) and the
merged droplet containing the MB-cell complexes is moved
in the leftward direction. As illustrated in FIGS. 5C and 5D,
the meniscus of the merged droplet is then swept first in the
leftward direction (FIG. 5C) followed by movement in the
rightward direction (FIG. 5D). This process leaves a higher
concentration of target cells bound to MBs on the leftmost
side of the droplet due to the magnetic attraction to the magnet
12. As seen in FIG. 5E, the droplet is then cut or split at a
location that is outside the region of the droplet containing the
target cells and bound MBs. The cut droplet 48 thus contains
non-target cells, thereby enriching to droplet 46 containing
the target cells. This process may be repeated by adding a
wash droplet containing a buffer or other solution as previ-
ously explained to further improve the enrichment of the
target cell types.
FIGS. 6A-6D illustrate another embodiment of a method
for enriching the concentration of a target species. The target
species may include a specific molecule or cell. In this
method, the adhesive forces between the surface 14 and the
MBs is reduced by the addition of a surfactant agent. The
surfactant agent may include hydrophilic (especially amphi-
pathic)polymersandpolymeric surface-acting agents. Inpar-
ticular, the surfactant agent may include non-ionic agents
such as polyhydric alcohol-type surfactants like fatty acid
esters of glycerol, pentaerythritol, sorbitol, sorbitan, etc., and
more hydrophilic agents made by their alkoxylation, includ-
ing polysorbates (TWEENO), polyethylene glycol-type sur-
factants such as PLURONIC surfactants (e.g., poloxamers),
polyethylene glycol (PEG), methoxypolyethylene glycol
(MPEG), polyacrilic acid, polyglycosides, soluble polysac-
charides, dextrins, microdextrins, gums, and agar. In addi-
tion, the surfactants could be ionic agents, including anionic
surfactants like salts of carboxylic acids (soaps), sulfuric
acids, sulfuric esters of higher alcohols, etc., cationic surfac-
tants like salts of alkylamine type, quarternary ammonium
salts etc., or amphoteric surfactants like amino acid type
8
surfactants and betaine type surfactants. Once the MBs are at
least partially surrounded by these molecules, the MBs that
settle to the surface 14 (e.g., under magnetic force, gravity,
etc.) have a much weaker adhesion force to the surface 14.
5 The surfactant agent may be pre-coated onto the MB's them-
selves. Alternatively, the surfactant agent may be added to the
solution containing MB's. Thus the fluid forming the various
droplets may include the surfactant agent therein. In the latter
case, the reduction in adhesive forces is more pronounced if
io the concentration of the surfactant agent increases. Generally,
however, exemplary concentrations for surfactant agents to
function effectively can range from below 0.01 % (on a weight
basis) to over 20% (on a weight basis). As a result, MBs on the
surface, which would otherwise not move upon the introduc-
15 tion of the magnet 12, readily do so and can be collected at the
desired location.
Thus, unlike the prior method discussed herein, there is no
need to move the droplet in a back in forth motion to sweep
the droplet meniscus across the MBs to suspend the MBs
20 
within the interior portion of the droplet. The addition of the
surfactant agent alone is sufficient to reduce the surface forces
between the MBs and the surface 14 such that the magnetic
forces from magnet 12 are sufficient to cause movement of the
MBs off of the surface 14.
FIGS. 6A-6D illustrates a process of using this method in
25 the context of cellular enrichment. Of course, it should be
understood that this method may also apply to the enrichment
of other target species such as, for instance, proteins, nucleic
acids, etc. FIG. 6A illustrates a droplet 50 containing a mix-
ture of different cell types. The target cells are the square-
30 shaped cells while the non-targets are the circular-shaped
cells. This droplet 50 is merged with a droplet 52 containing
MBs conjugated with Ab that is selective or recognizes the
target cells. Merging of the two droplets 50, 52 is accom-
plished using the underlying EWOD electrodes 10 although,
35 again, other forces may be employed to move, merge, and cut
the various droplets as explained herein. FIG. 6B illustrates
the merged droplet 54 along with the incubated complexes
formed between the target cells and the MB-Ab. The non-
target cells do not bind to the MB-Ab within the droplet. In
40 
this example, the droplet 54 itself contains the surfactant
agent. The surfactant agent may have been loaded into the
original droplet 50 containing the mixture of cells or the
droplet 52 containing the MB-Ab (or both droplets 50, 52).
Alternatively, the MBs may have been coated with the sur-
factant agent.
45 FIG. 6C illustrates a magnet 12 that is placed on one side of
the device. The magnet 12 may be a permanent magnet or,
alternatively, an electromagnetic. As seen in FIG. 6C, the
complexes of the target cells and the MB-Ab are drawn in the
leftward direction toward the magnet 12. Because of the
50 addition of the surfactant agent, the MBs located on the
surface 14 of the device can be readily lifted off the surface
and into the interior portion of the droplet 56. As seen in FIG.
6C, the MBs are concentrated in the left side of the droplet 56
while the non-target cells are distributed within the droplet
55 56. Next, as seen in FIG. 6D, the droplet 56 is cut or split at alocation that is outside the region of the droplet 56 containing
the MBs. The droplet 56 is cut using the underlying EWOD
electrodes 10 as explained herein. This cut of the droplet 56
forms one droplet 58 that includes an enriched concentration
of target cells due to the enrichment of the MBs while the
60 other cut droplet 60 contains non-target cells. As in the prior
embodiments, the droplet 58 may be further enriched using a
droplet containing a wash buffer or the like (not shown) along
with repeating operations illustrated in FIGS. 6C and 6D.
While the embodiment of FIGS. 6A-6D have been
65 described as an independent method of manipulating MBs, it
should be understood that the surfactant agent may be used in
conjunction with the methods illustrated in FIGS. 2A-20,
US 8,093,064 B2
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3A-3D, 4A-4F, and 5A-5E. The methods may be independent
or complementary as the case may be. It should be noted that
the addition of a surfactant agent can affect the wetting prop-
erties of the solution. As such, certain operations (like cutting)
may require additional droplet manipulation sequences. For
instance, an additional droplet free from surfactants may need
to be impinged upon the neck region of the stretched droplet
so as to help droplet splitting. However, these can still be
readily performed on microfluidic platforms including, for
instance, the EWOD platform described herein.
For applications where the use of chemical additives is
desirable for some other reasons, but where there is no
adverse effect of their addition, the method of FIGS. 6A-6D is
best suited. For instance, solutions rich in proteins such as
albumin and Horse Radish Peroxidase, that typically "foul'
the EWOD device, have been effectively actuated using
hydrophilic additives. See, e.g., International Publication No.
WO 2006/127451, which is incorporated by reference as if set
forth herein. In addition, magnetic concentration and separa-
tion of, for example, a target nucleic acid (e.g., DNA or RNA)
or protein from such a solution could most conveniently be
performed using the method of FIGS. 6A-6D.
However, surfactants and hydrophilic polymers are known
to affect cellular structure and functioning by influencing the
permeability of the cell membrane. Processes involving cells,
particularly over any significant length of time, may be influ-
enced by the chemical additives described above with respect
to the process of FIGS. 6A-6D. The method that utilizes back
and forth movement of a meniscus to sweep MBs off the
surface, on the other hand, is a purely physical technique and
hence free from such unwanted chemical interference with
cellular pathways. For such applications where the chemical
additives are undesirable and not otherwise required for
microfluidic actuation, it may be desirable to use the moving
meniscus technique. Examples of such applications include
studies involving yeast, bacteria, and other cells that do not
require protein-rich media.
In applications where the presence of surfactants is neither
necessary nor detrimental, both techniques are available to
use. A potential example of such an application is magnetic
separation of DNA and separation of non-biological mag-
netic and non-magnetic particles. By choosing the appropri-
ate method, these methods can be used for magnetic concen-
tration in droplet-based microfluidics over a wide range of
biological and non-biological applications. This includes
applications for the collection and separation of nucleic acids,
proteins, and cells. The methods described herein extend the
scope of digital microfluidics to a range of applications
involving target concentration. Performing biochemical
assays on a miniature microfluidic chip as opposed to con-
ventional techniques involving bulk fluids has many advan-
tages, including, portability, automation and integration of
functions, lower reagent consumption, and shorter reaction
times, among others. Droplet microfluidics is an upcoming
and promising microfluidics technology where liquids (or
gases) are transported in the form of packets or droplets,
enabling flexibility and re-programmability of fluid paths.
Techniques such as EWOD used for droplet microfluidics
employ simple devices with no moving parts (micropumps,
microvalves etc.) and consume very little power (<I mW),
making them ideal for portable devices required in point-of-
care diagnostic applications. Many such applications require
concentration of target analytes, e.g. target proteins in an
immunoassay. Separation of specific cells (e.g. CD8+ cells
from blood) using specific antibody conjugated magnetic
beads is another important application for lab-on-a-chip tech-
nology.
Microfluidics-based lab-on-a-chip devices are envisioned
as a revolutionary technology for biochemical detection, par-
ticularly for quick, low-cost, portable, automated "point-of-
care" systems. Droplet microfluidics enabled by EWOD is a
5 simple, low-cost, low-power, and reconfigurable microfluid-
ics technology ideally suited for the above requirements.
These methods allow implementation of the MB-based pro-
tocols and assays on the droplet-based microfluidic platform,
expanding the application window of such affordable, por-
10 table and powerful diagnostic devices enabled by droplet
microfluidics technologies.
While embodiments of the present invention have been
shown and described, various modifications may be made
without departing from the scope of the present invention.
The invention, therefore, should not be limited, except to the
15 following claims, and their equivalents.
What is claimed is:
1. A method of manipulating magnetic particles disposed
within a droplet that is located on or in close proximity to a
20 surface supporting the droplet, the method comprising:
moving a meniscus of the droplet back and forth so as to lift
the magnetic particles off the surface;
applying a magnetic field to the droplet containing the
magnetic particles, the magnetic field concentrating the
25	 magnetic particles in a region of the droplet; and
cutting the droplet at a location outside of the region con-
taining the magnetic particles.
2. The method of claim 1, wherein the magnetic particles
comprise magnetic beads.
30 3. The method of claim 1, wherein the magnetic field is
applied by a permanent magnet.
4. The method of claim 1, wherein the magnetic field is
applied by an electromagnet.
5. The method of claim 1, wherein the droplet is moved
relative to the magnetic field using a plurality of electrodes.
35 6. The method of claim 1, wherein a surfactant agent is
added to the droplet, or the magnetic particles are treated with
a surfactant agent, or the surface is treated with a surfactant
agent.
7. The method of claim 1, wherein the droplet is sur-
4o rounded by another liquid.
8. The method of claim 1, wherein the droplet is sur-
rounded by a gas.
9. The method of claim 1, wherein the droplet is moved by
using at least one of an electrowetting force, electrostatic
45 force, electromechanical force, electrophoretic force, dielec-
trophoretic force, electroosmotic force, thermocapillary
force, surface acoustic force, or pressure force.
10. The method of claim 1, wherein the magnetic particles
comprise magnetic particles conjugated with an antibody.
11. The method of claim 6, wherein the surfactant is
So selected from the group consisting of polysorbates, poloxam-
ers, polyethylene glycol (PEG), methoxypolyethylene glycol
(MPEG), polyacrilic acid, polyglycosides, soluble polysac-
charides, dextrins, microdextrins, gums, and agar.
12. The method of claim 1, further comprising merging the
55 cut droplet containing the magnetic particles with a droplet
containing a wash or buffer solution.
13. The method of claim 12, further comprising cutting the
merged droplet at a location outside of the region containing
the magnetic particles.
60	 14. The method of claim 5, wherein the droplet is cut using
the plurality of electrodes.
